Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Clinical Practice Guideline – Metastatic Breast Cancer

ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer

Published in 2021 - Ann Oncol. 2021(32)
Authors: A. Gennari, F. André, C. H. Barrios, et al, on behalf of the ESMO Guidelines Committee

  • This ESMO Clinical Practice Guideline provides key recommendations and algorithms for managing metastatic breast cancer.
  • It covers diagnosis, staging, risk assessment, treatment, disease monitoring, palliative care and the patient perspective.
  • ESMO-MCBS and ESCAT scores are given to describe the levels of evidence for treatment choices.
  • The authors comprise an international expert group, with recommendations based on available evidence and expert opinion.
  • In clinical practice, all recommendations provided need to be discussed with patients in a shared decision-making approach.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings